Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
169 Cards in this Set
- Front
- Back
What are the three types of opioid receptor?
|
mu
kappa delta |
|
To which type of opioid receptor does morphine have greatest affinity?
|
Mu
|
|
To which type of opioid receptor does codeine have greatest affinity?
|
Equally weak affinity to all 3
|
|
To which type of opioid receptor does naloxone have greatest affinity?
|
Almost equally strong affinity to all 3
|
|
To which type of opioid receptor does beta-endorphin have greatest affinity?
|
Equally strong affinity to all 3
|
|
T/F: beta endorphin is naturally occuring
|
true
|
|
Stimulation of kappa opioid receptors has what effect?
|
1.Analgesia at spinal level
2. Dysphoria |
|
stimulation of mu and delta receptors has what effect?
|
1. Analgesia (spinal and supraspinal)
2. Euphoria 3. Respiratory depression [decr. sensitivity to arterial CO2] 4. Decr. GI motility, incr. sphincter tone->constipation 5. Pupillary constriction [receptors in occulomotor nuc.] 6. Nausea and vomiting [area postrema feeds into chemoreceptor trigger zone] 7. Reduced cough reflex |
|
Are opiates effective for neuropathic pain?
|
No
|
|
Why does stimulation of mu receptor cause respiratory depression?
|
Dampens brainstem sensitivity to incr. in PaCO2 --> won't get increased ventilatory response to rises in CO2
|
|
What is the bioavailability (F) and half life of morphine?
|
F = 20-30%
t1/2 = short [2-3hrs] |
|
Describe metabolism of morphine
|
Phase II conjugation with GLUCURONIC ACID (added at 3rd and 6th position)
Get M-6-glucuronide and M-3-glucuronide |
|
T/F: M-3-glucuronide is twice as potent as morphine
|
False. M-6-glucuronide is twice as potent
|
|
What is the net analgesic effect of morphine and its metabolites?
|
Combination of morphine actions AND M-6-glucuronide actions.
M-3-G is inactive. |
|
What is the structural difference between codeine and morphine?
|
Codeine = 3-methyl-morphine (i.e. has methyl group at 3rd carbon, otherwise same)
|
|
What is the bioavailability of codeine cf. morphine? and why?
|
Codeine = 50%
Morphine = 20-30% due to the methyl group at 3rd carbon |
|
Which enzyme converts codeine to morphine?
|
CYP 2D6
to remember: coDEine (i.e. D) |
|
What is a "poor metaboliser of codeine"
|
Someone who has a polymorphism in their gene for CYP 2D6 --> can't convert codeine to morphine and don't get as much analgesia
[7-10% Caucasians are poor metabolisers] |
|
Difference between oxycodone and codeine?
|
Oxycodone NOT a pro-drug (c.f. codeine)
Oxycodone binds DIRECTLY to opiate receptors (i.e. full agonist) Oxycodone bioavailability - 80% (c.f. 50% codeine) |
|
Difference between endone and oxycontin?
|
Both oxycodone.
Endone - short acting (4-5hr duration) Oxycontin - sustained release (12hr duration) |
|
Give features of fentanyl
|
- mu agonist
- 60-80x more potent than morphine - lipid soluble (crosses BBB) - Short half life (3hrs) |
|
Give features of buprenorphine. What is it used for?
|
- partial mu agonist
- full kappa antagonist Used in treatment of opioid dependence |
|
What are some benefits of taking Tramadol?
|
Less constipation
Less respiratory depression Less addiction potential .....cf morphine |
|
Give features of Tramadol
|
Good oral bioavailability (70%)
Weak mu agonist inhibits NA uptake Enhances serotonin release |
|
Why should pethadine not be used?
|
Very short half life (2hrs) --> more addiction potential
Metabolite accumulates with renal impairment --> convulsions Lot of potential drug interactions |
|
Why is methadone used in oral maintenance programs for addicts?
|
- similar molecular actions to morphine
- little euphoria --> less potential for abuse - slow release from extracellular compartments (i.e. take once daily) |
|
What is heroin? Why can it cross the BBB so fast?
|
Di-acetyl morphine
--> more lipophilic than morphine so crosses the BBB |
|
Endogenous opioids are derived from...?
|
Larger polypeptide structures that have undergone post-translational modifications .
All contain enkephalin |
|
T/F: all opioid receptors are ionotropic
|
False. they are all metabotropic
|
|
What are the actions of opioids on their receptors?
|
1. Close Ca2+ channels
-->inhibit NT release 2. Open K+ leakage channels -->hyperpolarisation 3. Decrease AC activity --> less cAMP |
|
Why do mu receptors cause euphoria and kappa receptors cause dysphoria?
|
Depends on LOCATION OF RECEPTORS in mesolimbic dopaminergic pathway.
Cell bodies in VTA project to NAC and release DA. Mu receptors are on inter-neurons at the VTA. Stimulation will inhibit the inhibitory interneuron --> firing --> DA release in NAC Kappa receptors are found on nerve terminals in the NAC. Stimulation will decr. Ca2+ influx --> direct inhibition of DA release in NAC |
|
Difference between naltrexone and naloxone?
|
Naloxone = reversal of opioid overdose (short half life, give subQ because low oral availability, reverses opioid effect in seconds)
Naltrexone = used in management of opioid dependence. Longer acting (half life 14 hrs), high oral bioavailability |
|
What is a problem with using naltrexone?
|
Risk of OD if patient relapses, because their tolerance will have decreased if they haven't been using regularly
|
|
What is the normal nociceptive ascending pathway?
|
Peripheral pain receptors --> dorsal horn --> PAG in midbrain --> thalamus --> somatosensory cortex, anterior cingulate gyrus (emotional experience)
|
|
What role does the PAG play in pain perception?
|
The peri-aqueductal grey acts as a "gate" in the midbrain.
The PAG receives input from higher brain regions which activate a descending inhibitory system limiting the amount of nociception reaching brain. Basically STIMULATE PAG --> shut the gate to the ascending pain pathway at level of dorsal horn |
|
The limbic system is proposed to be involved in which part of pain perception?
|
Emotional
|
|
How do opioids provide analgesia at the level of the PAG?
|
Opioid receptors located on GABA interneurons in PAG.
Stimulate receptor --> inhibit GABA interneuron --> "take off the brakes" --> descending pathway activated --> ascending pain pathway inhibited (gate closes) |
|
T/F: Systemic NSAIDs potentiate opioid analgesia synergistically
|
FALSE.
Systemic NSAIDs potentiate opioid analgesia ADDITIVELY. |
|
Which route of administration of NSAIDs potentiates opioids synergistically?
|
SPINAL NSAIDs
|
|
How does combining opioids and spinal NSAIDs increase analgesia?
|
1. Opioid binds mu receptor on GABA interneuron in PAG.
2. G-protein activates PLA pathway 3. Arachidonic acid cleaved from cell membrane and converted to 12-lipoxygenase 4. Increased conduction of K+ channels 5. Inhibition of GABA interneuron 6. Excitation of descending pathway to inhibit ascending pain pathway. BUT - arachidonic acid is also converted to cyclooxygenase. NSAIDs inhibit cyclooxygenase --> more arachidonic acid to be converted to 12-lipoxygenase --> more analgesia (synergism) |
|
What percentage of the world's human population is infected with Hep C?
|
Approx. 3%
|
|
What percentage of acute Hepatitic C infections display overt clinical disease?
|
25%
|
|
T/F: People who have had clinical disease with acute Hep C infection are more likely to clear the infection entirely and not progress to chronic infection
|
True.
|
|
T/F: Majority of people will die from Hepatitis C
|
False.
Majority of infected individuals will die WITH disease, not FROM. |
|
What percentage of people will progress to chronic Hep C infection?
|
Approx 80%
|
|
What percentage of chronic Hep C infections will develop liver cirrhosis within 10 years?
|
Approx 40%
|
|
What percentage of chronic Hep C infections will develop hepatocellular carcinoma within 10 years?
|
Approx 20%
|
|
T/F: Hepatitis C virus ONLY infects hepatocytes
|
True
|
|
Why does the Hepatitis C virus mutate rapidly?
|
RNA virus --> RNA Pol has no proof-reading ability.
|
|
Hepatitis C Virus genotype 4 is predominent in which locations?
|
Egypt and Africa
|
|
Which Hepatitis C virus genotype is most difficult to treat?
|
Genotype 1
|
|
Which Hepatitis C virus genotype is most common?
|
Genotype 1 - responsible for 60% infections
|
|
What is the predominant mode of Hep C infection in Australia and North America?
|
IV drug use
|
|
What percentage of haemophiliacs are infected with Hep C and why?
|
Approx 90%
High transfusion rate-->high risk |
|
T/F: Prophylactic treatment can be given after Hep C virus exposure?
|
False - have to wait 12 weeks to see if become RNA +ve
|
|
What are some exposures known to be associated with Hep C infection?
|
- Injecting drug use
- transfusion, transplant from infected donor - occupational exposure to blood - unsafe injections - birth to HCV-infected mother (vertical transmission rate <6%) - Sex w/ infected partner |
|
Factors that are associated with faster HCV progression / worse response to treatment = ?
|
- Age at infection - better prognosis if younger
- Gender --> males are worse – less response to treatment, higher prevalence of chronic infection - Race – eg African-Americans have lower response rates to treatment and more severe cirrhosis - Alcohol – heavy alcohol drinking concurrent with infection --> more severe liver disease - HIV infection - Obesity (more likely to have fatty liver disease) - Haemachromatosis - Schistomiasis - Genetics |
|
How long does it take for anti-HCV antibodies to be detected in blood?
|
8-12 weeks
|
|
T/F: ALT levels predict liver damage
|
False
|
|
What serological features would you see with acute Hep C virus infection with RECOVERY?
|
- Initial HCV RNA which becomes and remains negative
- Rise in ALT which then drops - Still have anti-HCV Abs after cleared infection |
|
What serological features would you see with acute Hep C virus infection with PROGRESSION TO CHRONIC DISEASE?
|
- HSV RNA positive (because don't clear infection)
- Anti-HCV Abs - Initial peak in ALT which then fluctuate throughout chronic infection |
|
How do you test for HCV infection?
|
1. ELISA
if positive: 2. PCR - very sensitive to RNA |
|
When is treatment of Hep C NOT recommended?
|
- Persistently normal ALT
- Advanced or decompensated liver cirrhosis - Excessive alcohol use - Active drug use |
|
When is treatment of Hep C recommended?
|
- Detectable HCV RNA
- Persistently elevated ALT - Abnormal liver biopsy showing portal or bridging fibrosis, or at least moderate inflammation |
|
What are the predictors of a favourable response to HCV treatment?
|
- Genotype 2 or 3
- Low viral load - No or only portal fibrosis - Female - <40 yo |
|
The IL-28B gene on chromosome 19 encodes what?
|
IFN - lambda 3
|
|
Having the IL-28B gene on chromosome 19 is associated with what?
|
Encodes for IFN - lambda 3. (This is favourable!!)
People with this gene are -->MORE LIKELY to CLEAR THE VIRUS -->MORE LIKELY to RESPOND TO THERAPY Different polymorphisms in the promoter region of the gene have been linked to different success rates with treatment and also the rate of spontaneous clearance |
|
At 12 week follow-up after initiating HCV treatment, what drop in viral load is needed in order to continue treatment?
|
Need a 2 log drop in viral load
--> if less than that, the treatment isn't working! |
|
How do you treat HCV infection? What are some contra-indications?
|
IFNs and ribavirin
IFNs - side effects (constant flu like symptoms) Ribavirin - teratogenic, must take in conjunction with contraception |
|
What are the three levels of protection against viruses?
|
1. Physical barriers
2. Innate immune system 3. Adaptive immune system |
|
What are they 'key players' in the innate immune response against viruses?
|
Type I IFN, NK cells, inflammatory mediators (eg cytokines)
|
|
Outline the Herpesvirus life cycle
|
1. Attachment
2. Penetration 3. Uncoating 4. Gene expression and DNA replication 5. Assembly 6. Release of progeny virus |
|
Viral infection stimulates production of which type of interferon?
|
Type 1 IFN
|
|
Type I interferons function to:
1. _____ 2. _____ 3. _____ |
1. Inhibit viral infection and replication by inducing ANTI VIRAL STATE
2. Enhance cytotoxic T cell acvitiy 3. Enhance cytotoxic activity of NK cells |
|
What is an "anti viral state"
|
Whereby enzymes are induced within a cell to block viral replication.
IFN also acts on bystander cells - priming them to an anti-viral state |
|
How does type 1 IFN enhance T cell cytotoxicity?
|
IFN binds R on infected cell --> signalling cascade results in upregulation of class I MHC --> increased chance will be seen by CD8+ T cells
|
|
How does type 1 IFN block viral replication
|
Binding of IFN to receptor induces a signalling cascade that results in enzymes, such as those that degrade newly synthesised mRNA
|
|
NK cells recognise what?
|
Cells that fail to express MHC Class I
|
|
T/F: NK cells contain T cell genes
|
False
|
|
What type of cell are NK cells?
|
Large, granular lymphocytes
|
|
Which cytokines are involved in the innate immune response to viral infection?
|
TNF
IFN-gamma IL-1 IL-2 |
|
T/F: Antibodies are effective against viruses primarily during the intracellular phase of their life cycle
|
False. Extracellular
|
|
What type of antibodies are most effective in the extracellular phase?
|
Neutralising Abs - prevents virus binding to cell surface receptor
|
|
What process involving antibodies is most effective in the intracellular phase?
|
ADCC
|
|
What cytokine stimulates movement of DCs to the secondary lymphoid organs
|
TNF-alpha
|
|
Outline process of ADCC
|
1. Viral infected cell expresses viral proteins on surface
2. IgG binds infected cell (Fab region) 3. Fc region binds FcR on NK cells 4. NK cells activated, degranulate 5. Apoptosis of infected cell |
|
What do perforin and granzymes do?
|
Perforin = forms poly-perforin ring (i.e. hole) in infected cell membrane
Granzymes activate caspases - induce apoptosis |
|
How do viruses passively evade immune system?
|
- infect immune priviledged sites that don't have MHC (eg neurons)
- establish latent infections |
|
How do viruses aggressively evade immune system?
|
Infect and kill immune cells --> immunosuppression (e.g. HIV)
|
|
How do viruses actively evade innate immune system?
|
1. Interfere with type 1 IFN
-->some viruses encode IFN-R homolog that lacks transmembrane region -->inhibit intracellular signalling cascade 2. Interfere with other cytokine signalling networks e.g. TNF-R homologs 3. Evade NK killing --> HCMV expresses MHC-I homolog on surface that engages NK cells but not T cells |
|
How do viruses actively evade adaptive immune system?
|
1. Modulate ADCC
--> HCMV encodes surface protein that binds FcR so that it can't bind to NK cells 2. Antigenic variation by RNA viruses 3. Inhibit Class I or II pathways |
|
How do viruses interfere with MHC Class I presentation
|
- inhibition of generation of antigenic peptide
- Antigenic peptides transported via TAP complex - inhibition of MHC I surface expression |
|
How do viruses interfere with MHC Class II presentation
|
- inhibition of surface expression of MHC-II molecules (i.e. post-translational effects)
- inhibition of IFN-induced expression of MHC-II molecules (i.e. transcriptional effects) |
|
What are the 3 most common bloodborne viruses?
|
Hep B
Hep C HIV |
|
Outline features of Hep A
|
- transmitted by faecal-oral route
- acute infection = jaundice, yellow eyes, flu symptoms - body rapidly clears virus - 0.05% people get serious liver damage - virus in faeces when viraemic |
|
What proportion of community are anti-HCA Ab positive?
|
20-80%
|
|
Outline features of Hep B
|
- DNA virus
- Abs directed against core and surface proteins (vaccine only gives against surface) - infected for life (inserts into host genome) |
|
What does the E antigen in Hepatitis B indicate?
|
E antigen = marker of virulence
If positive for E antigen, indicates virus in high replicative state, probable high viraemia |
|
What is the most reliable predictor of long term sequelae from infection with Hep B?
|
DNA levels
|
|
How do you treat Hep B?
|
nucleotide analogs
|
|
What are transaminases?
|
released from dying hepatocytes in either acute or chronic infections
|
|
what is gGT?
|
inducible enzyme --> elevated after drinking a lot of alcohol
|
|
What liver function test results would you expect with IMPAIRED SYNTHETIC FUNCTION?
|
Raised bilirubin
Raised INR Decr. albumin levels |
|
what is INR?
|
coagulation factor - raised when have impaired synthetic function
|
|
Bilirubin relates to what?
|
Hepatocyte clearance and excretion into bilary tree
|
|
Raised levels of bilirubin indicates what
|
- Liver problems (conjugation of free bilirubin insufficient/obstruction of bilary ducts)
-RBC problem (incr. RBC turnover --> too much bilirubin for healthy liver to process) |
|
What is alpha-fetoprotein
|
marker for liver cancer
|
|
For example with a needlestick injury, what is the risk for bloodborne transmission of the following viruses:
1. Hep B 2. Hep C 3. HIV |
1. Hep B - very high (about 50% if not already immune)
2. Hep C - about 2% 3. HIV - 0.3% |
|
Raised ALT and AST suggest what?
|
Hepatocellular injury
|
|
What can 'collateral damage' in the liver cause?
|
- Acute swelling obstructs bile ducts
- Chronic inflammatory response causes fibrosis |
|
What are the steps in drug dependence treatment?
|
1.Establish a therapeutic relationship
2.Individualised assessment – look at them as an individual 3.Personalised feedback 4.Clarification of THEIR values and goals - not yours 5.Encouragement 6.Medication if necessary 7.Follow-up monitoring of their progress |
|
What is therapeutic Nihlism?
|
Therapeutic Nihilism = the generally untrue but continuing belief that drug users do not care about their health, don’t want to stop using, don’t want treatment and won’t benefit from it
|
|
T/F: addiction involves neurobiological dysfunction and is not just behavioural
|
TRUE.
Initial drug use may be voluntary, but established dependence is neurobiological syndrome |
|
What are some treatments for drug dependence that have sound clinical evidence?
|
Methadone
Buprenorphine Naltrexone Motivational interviewing |
|
T/F: Alcohol and opioid dependence have the worst compliance rates when compared with other chronic diseases
|
FALSE.
Treatment compliance is the same compared with other chronic diseases. Adherence is a concern for all chronic disorders! |
|
If treatment is intervention directed to an affected individual, which populations are the following aimed at:
1. Primary prevention 2. Secondary prevention 3. Tertiary prevention |
1. Primary prevention - NON-USERS
2. Secondary prevention - NON-DEPENDENT 3. Tertiary prevention - DEPENDENT |
|
What are the key differences between incidental and planned withdrawal states?
|
Incidental - typically severe (not motivated to reduce drug use, no preparation)
Planned - less severe (motivated to reduce drug use) |
|
What are the principles of withdrawal management?
|
- Establish relationship and goals
- stop substance use - monitor for withdrawal symptoms/signs - reduce dose steadily to zero/maintenance level |
|
What is the drug of choice in alcohol withdrawal management?
|
Diazepam, up to 1/52
|
|
T/F: Buprenorphine is more effective at 'detoxifying' than methadone
|
True
|
|
Difference between methadone and buprenorphine USE
|
Methadone - long term maintenance
Buprenorphine - partial agonist, daily dose for about 1 week permitting transition to maintenance treatments |
|
Who is at risk of benzodiazepine withdrawal?
|
Risk if >3 tablets/day for >3 months
|
|
What are the 3 stages that amphetamine/cocaine users go through once stopped using?
|
1. CRASH [9hrs-4days]
-->dysphoria, fatigue, depression 2. WITHDRAWAL [1-10wks] -->Anhedonia, fatigue, outbursts, intense craving 3. EXTINCTION [indefinite] --> Normal mood/interest in life --> Episodic craving in response to conditioned cues |
|
What percentage of regular ecstacy (MDMA) users develop DSM-IV criteria for dependence?
|
50%
|
|
List properties of buprenorphine
|
1. Long duration of action - not needed daily
2. Partial agonist - safer in OD 3. High receptor affinity- naloxone ineffective 4. High first pass metabolism - given sublingually |
|
What does combining naloxone and buprenorphine achieve?
|
Abuse deterrent preparation!
--> if taken as directed sublingually, only the buprenorphine is active --> if taken IV, buprenorphine is more active but naloxone also active and precipitates withdrawal symptoms |
|
What does disulfiram ("antabuse") do ?
|
Inhibits conversion of acetaldehyde to acetate
Alcohol: accumulation of acetaldehyde --> flushing syndrome |
|
What are some introduced diseases to the Indigenous population
|
Smallpox
TB Influenza Measles Whooping cough Venereal diseases |
|
When was smallpox officially eradicated?
|
1980
|
|
Who were the "missionaries" and when were they around?
|
1820s-1830s
Southeastern Australia - wanted to save Indigenous people from destruction |
|
What happened in Jervis Bay 1890?
|
Aboriginals petitioned for better conditions, boats, nets, schools, etc
|
|
What/when was the Australian Aboriginal Progress Association?
|
1925
First Aboriginal political organisation to create formal links b/w communities over wide area |
|
When was the Aboriginal Progressive Association established? by whom?
|
1937
By Bill Fergusen and Pearl Gibbs |
|
When did the Council for Aboriginal Rights make a film in Warburton Ranges?
What did they film? |
1957
Short film documenting appaling living conditions |
|
When and what was the "Freedom Ride"
|
Ted Noffs + Charles Perkins
1965 - 30 Sydney University students (including Aboriginal people) undertook a 2,300 km bus tour of northern NSW towns investigating and protesting discrimination against Aborigines |
|
What was the result of the 1967 referendum?
|
92% voted YES to include Aboriginals in the Census
|
|
When was the Land Rights Legislation passed?
|
Mid-late 1970s
|
|
when was the Royal Commission into Aboriginal Deaths in Custody established?
|
1987
|
|
When did Kev say sorry?
|
February 2008
|
|
T/F: Sclerosed veins (site of chronic injecting drug use) increase maternal morbidity in obstetric emergency
|
true
|
|
Microdeficiencies of which substances is often seen in injecting drug users
|
Vitamin B6 (pyroxidine)
Folate Vitamin B1 (thiamine) Significant anaemia |
|
What is hyperemesis gravid arum
|
Vomiting and nausea. Common in injecting drug users - futher diminishes macronutrient intake
|
|
What are the fetal risks of maternal heroin use during pregnancy
|
No specific congenital malformations attributible to heroin, BUT high rate of perinatal mortality reflects high incidence of antenatal problems
-->intra-uterine death -->retarded intra-uterine growth -->prematurity -->risk of fetal acquisition of infection |
|
Which mechanisms are responsible for antenatal problems in heroin users?
|
Repeated hypoxic episodes secondary to maternal withdrawal.
Chorioamnionitis (inflam. of fetal membranes) Chronic nutritional inadequacy Cigarette smoking |
|
What are the risks to baby after birth to a heroin using mother?
|
- Newly delivered baby may be OBTUNDED and require ventilation
- Specific opioid abstinence syndrome - Post-discharge failure to thrive, neglect, abuse |
|
T/F: Needle exchange programs contain the spread of HIV and Hep C equally
|
False.
Contain spread of Hep C LESS effectively. This may be due to ancillary equipment s.a. touriquets |
|
What are the common clinical presentations of infections resulting from injection of BACTERIALLY contaminated drugs
|
- local abcess at injection site
- acute bacteremia - prostration (abrupt failure of function or complete physical exhaustion) - acute septicaemia (commonly Staph aureus) - acute Staphylococcal bacterial endocarditis (commonly tricuspid valve) |
|
Infections from injection of VIRUS contaiminated drugs include:
|
- HIV infection with acute presentation (fever, rash, lymphadenopathy)
- Hepatitis B with acute or chronic presentation (jaundice, prodrome) - Hepatitis C with acute or chronic presentation (similar to Hep B) RARELY, other viral infections s.a. Hepatitis G, Hepatitis A, HTLV-1 |
|
T/F: Methadone injection may lead to extensive venous thrombophlebitis
|
True.
Note, thrombophlebitis = Inflammation of the wall of a vein with associated thrombosis |
|
What characterises opioid intoxication?
|
Drowsiness
Stupor Pin-point pupils Higher doses-coma, respiratory depression |
|
How is opioid intoxication managed?
|
Initial as for alcohol i.e. SEDATIVE
Establish airway, ensure adequate ventilation Naloxone if depressed breathing. [titrate against response as not to induce withdrawal state] |
|
What are some symptoms of opioid withdrawal? When do they begin / peak / end?
|
Begin 8-16hrs after last dose.
Peak @ 2-3 days End after 4-7 days Yawning, sweats, runny eyes and nose, hot and cold flushes, muscle and joint pain, restlessness, insomnia, nausea, vomiting, diarrhoea |
|
What is the Five Factor Model of personality?
|
Describes major measures/descriptors of personality (OCEAN)
Openness Conscientiousness Extroversion Agreeableness Neuroticism/emotional stability |
|
How does the Big 5 model differ from the Five Factor model of personality?
|
Big 5 replaces "openness" with INTELLECT
|
|
What is a personality disorder?
|
personality traits are inflexible and maladaptive and cause significant functional impairment or subjective distress
|
|
Which pre-morbid personality characteristics can be identified in people who later become addicts?
|
1. Disregard for rules of society/antisocial behaviour/diagnosis of antisocial personality disorder
2. Impulsive/sensation seeking traits 3. Low self-esteem/depression/anxiety |
|
What are the 4 types of Child Abuse
|
Physical
Sexual Emotional Neglect |
|
What are the 5 broad categories of domestic violence?
|
1. Physical abuse [criminal offence]
2. Psychological abuse 3. Economic abuse 4. Social abuse 5. Sexual abuse [criminal offence] |
|
What percentage of reported incidents of domestic violence involve victim = woman, perpetrator = man?
|
85-97% cases
|
|
What percentage of women have experienced an episode of domestic violence whilst in a married or de-facto relationship?
|
Estimated 23%
|
|
T/F: Women are more at risk of physical violence cf. sexual
|
True
|
|
Which populations are more at risk of domestic violence?
|
- Female
- Younger - Living in remote regions - Indigenous |
|
What percentage of women reported that their children had witnessed their experience of violence?
|
38%
|
|
What is the most frequently used drug in Australia and what percentage of adults use it? What percentage use weekly?
|
Alcohol.
82% adults drink it. 40% drink weekly. |
|
What proportion of the population drinks at levels which place them at risk of long-term harm
|
1 in 10
|
|
What proportion of the population smoke cigarettes regularly? What proportion of the population are "ex-smokers"?
|
1 in 5 smoke
1 in 4 ex-smokers |
|
Which is the most frequently used illicit drug? What proportion of population has tried it?
|
Cannabis.
1 in 3 have tried |
|
What proportion of the population has ever injected drugs?
|
1 in 50
|
|
What are the factors associated with higher risk of drug use?
|
Male
20-29yo English speaking b/ground Lower SES group Lower education level Unemployment Indigenous |